Norris Medicines Limited (BOM:524414)

Market Cap	133.51M -23.5%
Revenue (ttm)	94.44M +105.9%
Net Income	-5.60M
EPS	-0.56
Shares Out	10.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,327
Open	13.00
Previous Close	13.00
Day's Range	13.00 - 14.19
52-Week Range	12.00 - 22.10
Beta	-0.60
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About Norris Medicines

Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exp...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 33
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524414

Financial Performance

In fiscal year 2025, Norris Medicines's revenue was 58.20 million, an increase of 3.27% compared to the previous year's 56.36 million. Losses were -12.37 million, 4.28% more than in 2024.